![Jean-Yves Blay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Yves Blay
Directeur/Membre du Conseil chez
TRANSGENE
Profil
Jean-Yves Blay is currently an Independent Director at Transgene SA since 2022 and General Director at Centre Léon Bérard Lyon et Rhône-Alpes since 2014.
Former positions include Independent Member-Supervisory Board at Innate Pharma SA from 2017 to 2025, President of the European Organisation for Research & Treatment of Cancer from 2009 to 2012, Secretary of the Oncology Commission at Académie Nationale de Médecine FCP, and President of UNICANCER from 2019 to 2022.
Education includes a doctorate from Université Claude Bernard Lyon 1, conferred in 1994.
Postes actifs de Jean-Yves Blay
| Sociétés | Poste | Début |
|---|---|---|
| TRANSGENE | Directeur/Membre du Conseil | 25/05/2022 |
Centre Léon Bérard Lyon et Rhône-Alpes | Directeur Général | 01/01/2014 |
Anciens postes connus de Jean-Yves Blay
| Sociétés | Poste | Fin |
|---|---|---|
| INNATE PHARMA | Directeur/Membre du Conseil | 22/05/2025 |
UNICANCER
 UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center | President | 01/01/2022 |
European Organisation for Research & Treatment of Cancer
 European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | President | 01/01/2012 |
Académie Nationale de Médecine FCP
 Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine | Corporate Officer/Principal | - |
Formation de Jean-Yves Blay
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Université Claude Bernard Lyon 1
 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centre Léon Bérard Lyon et Rhône-Alpes | |
European Organisation for Research & Treatment of Cancer
European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | Commercial Services |
Académie Nationale de Médecine FCP
Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine | Commercial Services |
UNICANCER
UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center | Health Services |
Choisissez Zonebourse 
